Total Health

 

Total Health is the largest provider of free cancer care resources for people who are treating or living with cancer. Our programs arm cancer care teams with the latest research and strategies to improve patient outcomes.

For more info visit our website at Total Health.


 

2020 ASCO Highlights on Esophageal & HCC: CRT + Trastuzumab vs. CRT in Esophageal and GE Junction Adenocarcinomas, Trastuzumab/Pertuzumab to FLOT, Donafenib vs. Sorafenib in 1L Advanced HCC

112 views
September 16, 2020
Comments 0
Login to view comments. Click here to Login